The U.S. Food and Drug Administration Should Solidify the Legal Basis for Its Authority over Reproductive Cloning | Zendy

Bernard J. Siegel | Zendy; Arnold I. Friede | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The U.S. Food and Drug Administration Should Solidify the Legal Basis for Its Authority over Reproductive Cloning

Author(s) -

Bernard J. Siegel,

Arnold I. Friede

Publication year - 2013

Publication title -

stem cells and development

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.99

H-Index - 114

eISSN - 1557-8534

pISSN - 1547-3287

DOI - 10.1089/scd.2013.0385

Subject(s) - biology , cloning (programming) , human cloning , food and drug administration , confusion , jurisdiction , administration (probate law) , environmental ethics , law , political science , genetics , pharmacology , psychoanalysis , psychology , philosophy , computer science , programming language

The promise and potential of stem cell research is apparent. However, ethical questions still linger. There is as yet no consensus in the U.S. Congress on how to address the issue of reproductive cloning and media confusion of this and the quite separate issue of therapeutic cloning inhibits therapeutic advance. This paper outlines the need for the FDA to undertake a deliberate process, with input from all stakeholders, to authoritatively establish its jurisdiction over human reproductive cloning so as to foster the life-saving potential of therapeutic cloning.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research